How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Surgical Infection Surveillance Solutions Market
- By Solution Type: Software Solutions, Hardware Solutions, Services
- By Deployment Mode: On-Premise, Cloud-Based
- By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Infection Control Departments
- By Infection Type Monitored: Surgical Site Infections (SSI), Bloodstream Infections (BSI), Urinary Tract Infections (UTI), Pneumonia
- By Data Analytics Capability: Real-Time Surveillance, Predictive Analytics, Retrospective Analysis
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Software Solutions leads By Solution Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 17 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 289 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.171 →
- 12 Company Profiles 17 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Surgical Infection Surveillance Solutions Market report
A complete, evidence-based study - 12 chapters and 121 sections covering market size, segmentation across 5 axes, regional analysis and 17 company profiles, forecast to 2033.
Segmentation covered
Solution Type 3
Deployment Mode 2
End User 4
Infection Type Monitored 4
Data Analytics Capability 3
Companies profiled
3M Company
Becton
Dickinson and Company (BD)
Thermo Fisher Scientific Inc.
Cerner Corporation (now part of Oracle)
Epic Systems Corporation
Medtronic plc
Stryker Corporation
Hill-Rom Holdings
Inc. (now part of Baxter International)
Getinge AB
BioMérieux SA
+5 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
17 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →3M Company
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Thermo Fisher Scientific Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Cerner Corporation (now part of Oracle)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Epic Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Medtronic plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Stryker Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Hill-Rom Holdings
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Inc. (now part of Baxter International)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Getinge AB
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →BioMérieux SA
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Philips Healthcare
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.227 →Cardinal Health Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Smith & Nephew plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Johnson & Johnson (Ethicon)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →GE Healthcare
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.250 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,455M by 2033 · 9.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Software Solutions62.4
- Hardware Solutions18.3
- Services19.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,194M → $2,484M · 9.6%
Europe$832.4M → $1,685M · 9.2%
Asia Pacific$760.0M → $1,592M · 9.7%
Latin America$470.5M → $1,022M · 10.2%
Middle East and Africa$361.9M → $682.8M · 8.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.402026
9.412027
9.442028
9.442029
9.452030
9.472031
9.482032
9.492033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- 3M Company20.8
- Becton19.1
- Dickinson and Company (BD)7.5
- Thermo Fisher Scientific Inc.8.3
- Cerner Corporation (now part of Oracle)7.2
- Epic Systems Corporation9.0
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Solution Type18.1%
Deployment Mode24.4%
End User22.7%
Infection Type Monitored18.0%
Data Analytics Capability16.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.3
- Europe22.6
- Asia Pacific21.3
- Latin America13.7
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| 3M Company | 97 | 81 | 94 | 89 | 89 | 99 | 92 |
| Becton | 89 | 92 | 91 | 69 | 86 | 72 | 83 |
| Dickinson and Company (BD) | 81 | 65 | 75 | 84 | 62 | 85 | 75 |
| Thermo Fisher Scientific Inc. | 82 | 80 | 81 | 58 | 74 | 73 | 75 |
| Cerner Corporation (now part of Oracle) | 62 | 68 | 70 | 59 | 67 | 68 | 66 |
| Epic Systems Corporation | 60 | 51 | 71 | 66 | 52 | 63 | 61 |
| Medtronic plc | 65 | 41 | 58 | 60 | 42 | 45 | 52 |
| Stryker Corporation | 37 | 48 | 55 | 59 | 53 | 40 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- 3M Company
- Becton
- Dickinson and Company (BD)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| 3M Company | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| Becton | ◐ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Dickinson and Company (BD) | ✓ | ◐ | − | ✓ | ◐ | ✓ |
| Thermo Fisher Scientific Inc. | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Cerner Corporation (now part of Oracle) | ✓ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Epic Systems Corporation | − | − | ◐ | ✓ | ◐ | ◐ |
| Medtronic plc | ✓ | − | ◐ | − | − | − |
| Stryker Corporation | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →13M Company92
2Becton83
3Dickinson and Company (BD)75
4Thermo Fisher Scientific Inc.75
5Cerner Corporation (now part of Oracle)66
6Epic Systems Corporation61
7Medtronic plc52
8Stryker Corporation49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
3M CompanyBecton
Challenger2
Strong scale, closing on the leaders.
Dickinson and Company (BD)Thermo Fisher Scientific Inc.
Contender2
Focused players with pockets of strength.
Cerner Corporation (now part of Oracle)Epic Systems Corporation
Niche2
Specialists in a single segment or region.
Medtronic plcStryker Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Solution Type in North America, then scale across Surgical Infection Surveillance Solutions Market — a $519M beachhead inside a $8.13B market.
Beachhead (SOM)$519Mobtainable near-term
Serviceable (SAM)$3.00Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Software Solutions
Best fit — highest urgency & budget in Solution Type.
Economic buyer77 fit
Hardware Solutions
Strong fit — clear ROI and a fast path to value.
End user69 fit
Services
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Solution Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Deployment Mode & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel28%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Solution Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Surgical Infection Surveillance Solutions Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified43%
Sales qualified25%
Evaluation15%
Closed-won6%
$17.6KCAC
$62KLTV
3.5:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Surgical Infection Surveillance Solutions Market is a durable-growth opportunity — $10.2B by 2033, compounding at 7.8%.
TAM · 2025$5.57Btoday
TAM · 2033$10.2Bforecast
CAGR7.8%2027–2033
Cumulative$69.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$10.2BTotal addressable market
SAM$3.66BServiceable available market
SOM$748MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.8% CAGR
Demand compounds through 2033, outpacing GDP across Solution Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Solution Type moving from early to mainstream — durable secular demand.
Consolidation upside
17+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$10.2BLarge & growingTAM by 2033 at 7.8% CAGR
$3.66BServiceable nowreachable with today’s model
$748MBeachhead winobtainable near-term share
17+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$7.94BBear5.1% CAGR
$10.2BBase7.8% CAGR
$13.0BBull10.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Deployment Mode optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Surgical Infection Surveillance Solutions Market — a $4.84B market by 2033. Plan: grow share from 8.4% to 16.3%.
Market size · 2033$4.84Btotal addressable
Market CAGR10.9%2027–2033
Target share16.3%from 8.4% today
Revenue ambition$789Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.4% | 16.3% | On track |
| Revenue | $377M | $789M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 36.5% | 45.8% | On track |
| Customer retention | 86.2% | 96.0% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Solution Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Deployment Mode capability
A defensible second engine — invest in Deployment Mode to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Solution Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Deployment Mode
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $98M capacity & capability investment
- Greenlight bolt-on M&A in Deployment Mode
- Authorise North America expansion plan
- Fund R&D program for Solution Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Surgical Infection Surveillance Solutions Market conversation — a $1.16B market you can size, segment and defend in minutes.
Market size · 2033$1.16Btotal opportunity
Growth3.6%CAGR to 2033
Addressable buyers1,584+accounts in scope
Typical ROI6.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Solution Type
Goal Grow share in Solution Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.1×return on cost, year one
< 3 mopayback period
$86K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
17+players profiled in this market
Coverage includes
3M CompanyBectonDickinson and Company (BD)Thermo Fisher Scientific Inc.Cerner Corporation (now part of Oracle)Epic Systems CorporationMedtronic plcStryker Corporation+9 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Surgical Infection Surveillance Solutions Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Surgical Infection Surveillance Solutions Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Surgical Infection Control Supplies Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportSurgical Infection Control Products Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportSurgical Hooks Market
Market size, share, segmentation and regional forecast.
$3.2B market · 2025 base year
View reportSurgical High Frequency Electrosurgical Knife Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportSurgical Hernia Stent Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportSurgical Hemostatic Sponge Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportSurgical Hemostatic Material Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportSurgical Hemostatic Forceps Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportSurgical Hemostatic Agents Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportSurgical Helmet System Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportSurgical Helmet Equipment Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportSurgical Helmet Cover Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.